Trial Profile
A pharmacokinetic study to evaluate once-daily regimen of sirolimus, minimized dose of prolonged-release tacrolimus in kidney transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 12 Nov 2016 New trial record